Loading insider details...
Beta
Latest Form 4 (Sep 18, 2026): Exercise/Conversion of 20,000 DNTH shares, $357.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 18, 2026 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Exercise/Conversion | 20,000 | $357.6K |
| Mar 14, 2026 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Exercise/Conversion | 16,182 | $289.3K |
| Feb 4, 2026 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 55,000 | n/a |
| Feb 4, 2025 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 60,000 | n/a |
| May 29, 2024 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 60,000 | n/a |
| Jan 26, 2024 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 80,000 | n/a |
| Oct 9, 2021 | ABEONA THERAPEUTICS INC. (ABEO) | Sale | 29,122 | $30.6K |
| Aug 12, 2021 | ABEONA THERAPEUTICS INC. (ABEO) | Grant/Award | 238,000 | n/a |
| Apr 5, 2021 | ABEONA THERAPEUTICS INC. (ABEO) | Sale | 20,445 | $37.9K |
| Mar 3, 2021 | ABEONA THERAPEUTICS INC. (ABEO) | Grant/Award | 50,000 | n/a |